<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        22-887-17
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TRANDATE 100MG TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LABETALOL HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tablet Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ASPEN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ASPEN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ASPEN
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AG01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1. What Trandate is and what it is used for:</strong></p><p>Please be aware that your doctor may have prescribed this medicine for another use and/or at another dosage than stated in the leaflet . Always follow the doctor&#39;s instructions that are stated on the pharmacy label on the bottle.</p><p>Trandate contains the active substance labetalol , It is used to treat mild, moderate or severe hypertension (high blood pressure), hypertension in pregnancy (pregnancy &ndash; induced high blood pressure) and high blood pressure associated with angina pectoris (chest pain).</p><p>Labetalol (trandate) belongs to a group of medicines called alpha- and beata-blocking agents, These medicines lower blood pressure by blocking receptor in the cardiovascular (circulatory) system, causing a decrease in blood pressure in the blood vessles far from the heart.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2. What you need to know before you take Trandate Do not take Trandate.</strong></p><ul><li>&nbsp; If you have a particular type of serious heart disease (second or third degree heart block, cardiogenic shock)</li><li>&nbsp;If you have serious or ongoing low blood pressure and other associated conditions ( your doctor will tell you which ones)</li><li>If you have an extremely slow heart rate (severe bradycardia)</li><li>If you have asthma or a history of a particular type of serious lung disease ( obstructive airways disease).</li><li>&nbsp;If you are allergic to labetalol of any of the other ingredients of this medicine ( listed in section 6).</li></ul><p><strong>Warnings and precautions:</strong></p><p>Talk to your doctor or pharmacist before you take Trandate:</p><ul><li>&nbsp;If you have reduced liver function or liver damage.</li><li>&nbsp; If you have problems with your peripheral circulation (peripheral vascular disease).</li><li>&nbsp; If you have a problem with the electrical conduction system in your heart (first-degree atrio-ventricular block)</li><li>&nbsp;If you have diabetes.</li><li>If you have an overactive thyroid (thyrotoxicosis, hyperthyroidism).</li><li>If you have previously had a severe allergic reaction (anaphylaxis) to any substance.</li><li>&nbsp;If you&nbsp; are aware that you may have to take adrenaline.</li><li>If you have heart failure or problems with your heart (poor left ventricular systolic function).</li><li>&nbsp;If you have phaeochromocyoma ( a particular type of tumour of the adrenal gland.</li></ul><p>If any of the above apply to you, you must tell your doctor before you take trandate.</p><p>If you develop a low heart rate ( bradycardia) as a result of taking Trandate, you doctor will lower your dose.</p><p>If you develop skin rashes and/or dry eyes or any kind of allergic reaction when you are taking trandate, contact your doctor as they may reduce or discontinue your treatment.</p><p>Always follow your doctor&#39;s instructions.</p><p>Do not stop taking Trandate suddenly, particularly if you have heart disease ( ischaemic heart disease) Talk to your doctor if you think you should stop taking Trandate.</p><p><strong>Surgery:</strong></p><p>Labetalol can affect you pupils during cataract surgery, tell your eye surgeon ahead of your surgery that you are using this medication , do not stop taking labetalol before surgery unless your surgeon tells you to.</p><p>If you are having surgery and will be given inhaled anaesthetics, you must tell your surgeon ahead of your surgery that you are taking trandate.</p><p><strong>Other medicines and trandate:</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>You must tell your doctor if you are taking, or aware you may have to take, any of the following medications before you take trandate:</p><ul><li>&nbsp;Any prostaglandin synthetase inhibitors (non &ndash; steroidal anti &ndash; inflammatory drugs) which are used to treat pain and inflammation.</li><li>&nbsp;Digoxin (heart medication).</li><li>Adrenaline which may be used to treat serious anaphylactic (allergic) reactions.</li><li>Medicines for heart disorders (class I antiarrhythmic agents).</li><li>Other medicines that lower blood pressure (calcium antagonists of the verapamil type).</li><li>Tricyclic anti-depressants (used for the treatment of depression).</li><li>Cimetidine (for ulcers and heartburn).</li></ul><p><strong>Tests:</strong></p><p>This medicine may interfere with certain medical/ laboratory tests, possibly causing false test results, make sure laboratory personnel and all your doctors know you use this medicine.</p><p><strong>Pregnancy and breast-feeding:</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>It is possible that the foetus may be affected. If you are pregnant, ask your doctor for advice before taking trandate.</p><p>Trandate is excreted in breast milk in small amounts. If you are breast-feeding, ask your doctor for advice before taking trandate.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>It is possible that the foetus may be affected. If you are pregnant, ask your doctor for advice before taking trandate.</p><p>Trandate is excreted in breast milk in small amounts. If you are breast-feeding, ask your doctor for advice before taking trandate.</p><p><strong>Driving and using machines:</strong></p><p>It is likely that trandate does not affect the ability to drive a vehicle or use machinery. Some people may, however, occasionally experience dizziness and/or fatigue, you should be aware that this may impair your ability to react, and therefore you should exercise caution until you are familiar with your reactions to this medicine.</p><p><strong>Trandate contains lactose: </strong></p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. How to take Trandate:</strong></p><p>Always take this medicine exactly as your doctor or pharmacist has told you , check with your doctor or pharmacist if you are not sure.</p><p><strong>Trandate tablets should be taken with food:</strong></p><p>The dose is determined by your doctor, who will adiust it individually for you the usual starting dose in 100 mg two times daily, typically, the doses up to 800 mg per day may control your blood pressure, up to 2400 mg (divided into 3 or 4 doses) per day may be given.</p><p>If you are an older person or if you have reduced liver function, your doctor may prescribe a lower dose</p><p>If you think that the effect of trandate is to strong or too weak, you should tell your doctor or pharmacist about this.</p><p><strong>If you take more trandate than you should:</strong></p><p>Symptoms of labetalol (trandate) overdose include extreme dizziness when you move to an upright position (sitting or standing) and sometimes low heart rate which you will feel as a low pulse. (bradycardia) contact a doctor, hospital or the national poison information centre if you think you have taken too much of this medicine or if a child has accidently ingested the medicine.</p><p><strong>If you forget to take trandate:</strong></p><p>Do not take a double dose to make up for a missed dose.</p><p>Contact your doctor if you are unsure.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4. Possible side effects:</strong></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Very common: may affect more than 1 in 10 people</strong></p><ul><li>Antibodies which are not associated with a disease.</li></ul><p><strong>Common : may affect up to 1 in 10 people:</strong></p><ul><li>&nbsp;Hypersensitivity (allergic reaction) rash and fever caused by this medicine.</li><li>Dizziness, headache and tingling sensation in the scalp which are normally temporary and occur during the first few weeks of treatment.</li><li>Blurred vision.</li><li>Congestive heart failure.</li><li>&nbsp;Dizziness if you move too quickly from a lying to a sitting position, or from a sitting to a standing position, due to low blood pressure (postural hypotension).more common at very high doses or if the initial dose is too high or doses are increased too rapidly. This is normally temporary and occurs during the first few weeks of treatment.</li><li>Congestion in your nose which is normally temporary and occurs during the first few weeks of treatment.</li><li>&nbsp; Nausea.</li><li>&nbsp; Raised liver function tests. This is usually reversible on withdrawal of the medicinal product.</li><li>Difficulty passing urine.</li><li>&nbsp;Erectile dysfunction (impotence) and ejaculatory failure.</li><li>Tiredness and lack of energy which are normally temporary and occur during the first few weeks of treatment.</li></ul><p>Allergic reactions (hypersensitivity) may also include rash (of varying severity), itching, shortness of breath and very rarely fever or rapid swelling of the skin.</p><p><strong>Uncommon: may affect up to 1 in 100 people:</strong></p><ul><li>&nbsp;Depressed mood which is normally temporary and occurs during the first few weeks of treatment.</li><li>Tightening of the bronchial muscles (bronchospasm).</li><li>&nbsp;Vomiting and pain in your abdomen, immediately below your ribs.</li><li>&nbsp;Sweating which is normally temporary and occurs during the first few weeks of treatment.</li><li>&nbsp;Muscle cramps.</li></ul><p><strong>Rare : may affect up to 1 in 1.000 people:</strong></p><ul><li>&nbsp;Low heart rate which may be felt as a low pulse (bradycardia).</li></ul><p><strong>Very rare: may affect up to 1 in 1.000 people:</strong></p><ul><li>Tremor when trandate is being used to treat high blood pressure associated with pregnancy.</li><li>&nbsp;Eye irritation.</li><li>Disruption of the electrical pulses that control the heart beat (heart block).</li><li>&nbsp;Worsening of the symptoms of raynaud&#39;s syndrome (cold fingers due to contraction of the small arteries).</li><li>Inflammation of the liver (hepatitis) which is usually reversible on withdrawal of the medicinal product.</li><li>Hepatocellular jaundice (skin and the whites of the eyes turn yellow) cholestatic jaundice (symptoms include fatigue and nausea followed by pruritus, dark urine and jaundice and may include rash or fever) and hepatic necrosis (damaged liver tissue), these symptoms are usually reversible on withdrawal of the medicinal product.</li><li>&nbsp;Muscle inflammation and weakness caused by the medicine (toxic myopathy).</li><li>&nbsp;Systemic lupus erythematous which has symptoms including joint pain, fever, skin rash and tiredness.</li><li>&nbsp;Inability to urinate at all even though you have a full bladder (a medical emergency).</li><li>Swelling of your ankles, this is normally temporary and occurs during the first few weeks of treatment.</li></ul><p><strong>Reporting of side effects:</strong></p><p>If you get any side effects, talk to your doctor, pharmacist of nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system. By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5. How to store Trandate:</strong></p><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the cartoon and bottle after EXP.</p><p>Do not store above 25 C.</p><p>Do not use this medicine if you notice signs of deterioration.</p><p>Do not throw away any medicines via wastewater of household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Trandate contains:</strong></p><ul><li>The active substance is labetalol hydrochloride . One tablet contains 100 mg or 200 mg of labetalol hydrochloride.</li><li>The other ingredients are, tablet core: lactose anhydrous, magnesium stearate, microcrystalline cellulose,&nbsp;&nbsp;film coating : Opaspray orange M=1-3499D (dye containing sodium benzoate (preservative E211), hypromellose, titanium dioxide (E171), sunset yellow (E110) and hypromellose.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Trandate looks like and contents of the pack:
Trandate 100 mg film-coated tablets are orange, round. Curved, biconvex, 8 mm, engraved GS SC5 on one side , A pack consists of a polypropylene containers with low density polyethylene caps containing 50, 75 , 100, 250 tablets. 
Trandate 200 mg film-coated tablets are orange, round, biconvex, 9.5 mm, engraved GS FC7 on one side. A pack consists of a polypropylene containers with low density polyethylene caps containing 50 , 75 , 100 , 250 tablets. 
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing authorisation holder: </strong></p><p>Aspen Pharma Trading LTD.</p><p>3016 lake drive, citywest business campus, Dublin 24.</p><p><strong>Manufacturer:</strong></p><p>Aspen Bad Oldesloe GmbH</p><p>Industriestr 32-36.</p><p>D- 23843 Bad oldesloe.</p><p>Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in { 03/2014} version {1}
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>1-&nbsp; ما المقصود بالدواء ترانديت ؟ وما دواعي استخدامة؟</strong></p><p dir="RTL">يرجى إدارك أن الطبيب المعالج لك قد يصف لك هذا الدواء لعلاج مرض أخر غير المنصوص عليه في هذه النشرة و / أو بجرعة مختلفة عن المذكورة هنا أيضاً يجب دائماً اتباع تعليمات الطبيب المدونة على ملصق الصيدلية الموجود على العبوة.</p><p dir="RTL">يحتوي ترانديت على المادة الفعالة لا بيتالول ، يستخدم هذا الدواء لعلاج &nbsp;فرط ضغط الدم (ضغط المرتفع) البسيط أو المتوسط أو الشديد وفرط ضغط الدم في الحمل (ضغط الدم المرتفع بسبب الحمل) وضغط الدم المرتفع المقترن بالذبحة الصدرية.</p><p dir="RTL">تنتمي مادة لابيتالول (ترانديت) إلى فئة من الأدوية تسمى حاصرات ألفا وبيتا تخفض هذه الأدوية ضغط الدم عن طريق حصر المستقبلات في الجهاز القلبي الوعائي (الجهاز الدوري) مما يسبب انخفاضاً في ضغط الدم في الأوعية الدموية البعيدة عن القلب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>2- ما الذي ينبغي ان تعرفه قبل استخدام ترانديت؟</strong></p><p dir="RTL"><strong>موانع&nbsp;استخدام ترانديت:</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; إذا كنت مصاباً بمرض خطير في القلب من نوع معين ( احصار القلب من الدرجة الثانية أو الثالثة صدمة قلبية المنشأ).</li><li>&nbsp; &nbsp; إذا كنت مصاباً بهبوط شديد أو مستمر في ضغط الدم وأمراض أخرى مقترنة بذلك (سيخبرك الطبيب بها).</li><li>&nbsp; &nbsp; إذا كنت تعاني من بطء شديد للغاية في نبض القلب (بطء القلب الشديد).</li><li>&nbsp; &nbsp; إذا كنت مصاباً بالربو أو عندك تاريخ لمرض رئوي خطير ( داء انسداد الممرات الهوائية).</li><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من الحساسية تجاه مادة لابيتالول أو أي من المكونات الأخرى في هذا الدواء (المذكورة في القسم 6).</li></ul><p dir="RTL"><strong>التحذيرات والاحتياطات:ـ</strong></p><p dir="RTL">ينبغي استشارة الطبيب أو الصيدلي قبل استخدام ترانديت في الحالات التالية:</p><ul dir="rtl"><li>&nbsp; &nbsp; قصور وظائف الكبد أو تلف الكبد.</li><li>&nbsp; &nbsp;وجود مشكلات في الدورة الدموية المحيطية (داء الأوعية المحيطية).</li><li>&nbsp; &nbsp; وجود مشكلة في جهاز التوصيل الكهربائي في القلب (إحصار أذيني بطيني من الدرجة الأولى).</li><li>&nbsp; &nbsp;الإصابة بالداء السكري.</li><li>&nbsp; &nbsp; الإصابة بفرط نشاط الغدة الدرقية (تسمم درقي ، فرط الدرقية).</li><li>&nbsp; &nbsp;الإصابة بحساسية شديدة سابقاً (تأق) تجاه أي مادة دوائية.</li><li>&nbsp; &nbsp; إذا كنت تعلم أنك تحتاج إلى أخذ الأدرينالين.</li><li>&nbsp; &nbsp; إذا كنت مصاباً بفشل القلب أو مشكلات في القلب (ضعف الوظيفة الانتقباضية للبطين الأيسر).</li><li>&nbsp; &nbsp; &nbsp; إذا كنت مصاباً بورم القوائم (نوع معين من أورام الغدة الكظرية)</li></ul><p dir="RTL">إذا كان أي من هذه الحالات ينطبق عليك ، فأخبر الطبيب قبل استخدام ترانديت.</p><p dir="RTL">إذا أصبت ببطء نبض القلب (بطء القلب ) بسبب تناول ترانديت فسيقوم الطبيب بخفض الجرعة لك.</p><p dir="RTL">إذا أصبت بطفح جلدي و / أو جفاف العينين أو أي نوع من الحساسية عند استخدام ترانديت ، فأتصل بالطبيب لأنه قد يقرر خفض الجرعة أو إيقاف العلاج يجب اتباع تعليمات الطبيب دائماً.</p><p dir="RTL">لا تتوقف عن تناول ترانديت بشكل مفاجئ خصوصاً إذا كنت مصاباً بمرض قلبي (داء القلب الإقفاري) يجب استشارة الطبيب إذا كنت &nbsp;تظن انك ينبغي أن تتوقف عن استخدام ترانديت.</p><p dir="RTL"><strong>الجراحة:</strong></p><p dir="RTL">يمكن أن تؤثر مادة لابيتالول على حدقة العين أثناء إجراء جراحة الساد (كتاراكت) يجب إخبار جراح العيون قبل إجراء العملية الجراحية بأنك تستخدم هذا الدواء ، لذا لا تتوقف عن تناول لابيتالول إلا إذا أمرك الطبيب الجراح بذلك.</p><p dir="RTL">إذا كنت ستخضع لعملية جراحية وسوف تعطي مواد مخدرة مستنشقة فيجب اخبار الجراح قبل العملية بأنك تستخدم ترانديت.</p><p dir="RTL"><strong>الأدوية الأخرى وترانديت:</strong></p><p dir="RTL">يرجى اخبار الطبيب أو الصيدلي إذا كنت تتناول حالياً &ndash; أو تناولت مؤخراً أي أدوية أخرى.</p><p dir="RTL">يجب عليك اخبار الطبيب إذا كنت تستخدم &ndash; أو تعلم أنك سوف تستخدم &ndash; أياً من الأدوية التالية قبل استخدام ترانديت:</p><ul dir="rtl"><li>&nbsp; &nbsp; أي مثبطات انزيم سينثيتاز بروستا جلادندين (مضادات الالتهابات غير الستيرويدية ) المستخدمة لعلاج الألم والالتهاب.</li><li>&nbsp; &nbsp; &nbsp;ديجوكسين (عقار للقلب).</li><li>&nbsp; &nbsp; &nbsp;الأدرينالين الذي قد يستخدم لعلاج تفاعلات التاقي (الحساسية).</li><li>&nbsp; &nbsp; أدوية اضرابات القلب (مضادات اضطراب النظم من الفئة الأولى).</li><li>&nbsp; &nbsp; الأدوية الأخرى التي تخفض ضغط الدم (مضادات الكالسيوم من نوع&nbsp; فيراباميل).</li><li>&nbsp; &nbsp; &nbsp; مضادات الاكتئاب ثلاثية الحلقات (لعلاج الاكتئاب).</li><li>&nbsp; &nbsp; &nbsp;سيميتدين (لعلاج القرحة وحرقة المعدة).</li></ul><p dir="RTL"><strong>الفحوص والاختيارات:</strong></p><p dir="RTL">قد يتداخل هذا الدواء مع فحوص طبية / مختبرية معينة وقد يسبب خطأ في نتائج الاختبارات والفحوص يجب الحرص على اخبار فنيي المختبر&nbsp; وكل الأطباء المعالجين لك بأنك تستخدم هذا الدواء.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية:</strong></p><p dir="RTL">إذا كانت المريضة حاملاً أو تظن أنها قد تكون حاملاً أو إذا كانت تخطط للإنجاب أو إذا كانت ترضع رضاعة طبيعية ، فينبغي استشارة الطبيب قبل تناول هذا الدواء.</p><p dir="RTL">من الممكن أن يتأثر الجنين بهذا الدواء إذا كانت المريضة حاملاً ، فيجب عليها استشارة الطبيب قبل استخدام ترانديت.</p><p dir="RTL">تفرز مادة ترانديت في لبن الثدي بكميات قليلة إذا كانت المريضة أما مرضعة ، فيجب عليها استشارة الطبيب قبل استخدام ترانديت.</p><p dir="RTL"><strong>قيادة المركبات واستخدام الآلات:</strong></p><p dir="RTL">من المحتمل ألا يؤثر ترانديت على القدرة على قيادة السيارات أو استخدام الآلات ولكن قد يصاب بعض الأفراد بدوار و/ أو تعب أحياناً وينبغي العلم بأن هذا قد يضر بقدرتك على التفاعل ومن ثم ينبغي توخي الحذر حتى تعتاد على استجابة جسمك لهذا الدواء.</p><p dir="RTL"><strong>أحتواء ترانديت على اللاكتوز:</strong></p><p dir="RTL">إذا كان الطبيب قد أخبرك أنك لا تتحمل بعض أنواع السكر ، فاتصل بالطبيب قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>3.كيفية تناول ترانديت:ـ</strong></p><p dir="RTL">ينبغي الحرص دائماً على تناول هذا الدواء حسب إرشادات الطبيب أو الصيدلي تماماً بتمام ينبغي استشارة الطبيب أو الصيدلي في حالة عدم التأكد من كيفية الاستخدام.</p><p dir="RTL">ينبغي اخذ أقراص ترانديت مع الطعام.</p><p dir="RTL">تحدد الجرعة بواسطة الطبيب وهو الذي سيضبطها حسب حالتك الفردية جرعة البداية العادية هي 100مجم مرتين في اليوم عادة سيتم ضبط ضغط الدم لديك بجرعة تصل إلى 800مجم في اليوم ويمكن إعطاء المريض جرعة تصل إلى 2400مجم (تقسم إلى 3 أو 4 جرعات ) في اليوم.</p><p dir="RTL">إذا كنت مسناً أو تعاني من قصور وظائف الكبد ، فقد يصف لك الطبيب جرعة منخفضة.</p><p dir="RTL">إذا كنت تظن أن مفعول ترانديت قوي أكثر من اللازم أو ضعيف أكثر من اللازم ، فينبغي أن تخبر الطبيب أو الصيدلي بذلك.</p><p dir="RTL">في حالة تناول جرعة زائدة من ترانديت عن الجرعة الموصوفة تشمل أعراض تناول جرعة مفرطة من مادة لا بيتالول (ترانديت) دوار مفرط عند اتخاذ وضع قائم للجسم (الجلوس أو الوقوف ) وأحياناً انخفاض سرعة القلب الذي ستشعر به في بطء نبض القلب (بطء القلب) اتصل بالطبيب أو مستشفى أو مركز معلومات السموم الوطني إذا ظننت أنك أخذت جرعة مفرطة من هذا الدواء أو إذا أخذ طفل لديك جرعة من هذا الدواء عن طريق الخطأ.</p><p dir="RTL"><strong>في حالة نسيان جرعة ترانديت:ـ</strong></p><p dir="RTL">لا تأخذ جرعة مزدوجة لتعويض الجرعة&nbsp; الفائتة ينبغي استشارة الطبيب إذا كنت غير متأكد من هذا.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء ، فأسأل الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>4- الآثار الجانبية الممكنة:</strong></p><p dir="RTL">مثل كل الادوية يمكن أن يسبب هذا الدواء آثاراً جانبية وأن كانت لا تحدث في جميع الأشخاص الذي يستخدمونه .</p><p dir="RTL"><strong>الآثار الجانبية الشائعة جداً ، يمكن أن تؤثر في أكثر من مريض واحد من كل 10 مرضى:</strong></p><ul dir="rtl"><li>&nbsp;اجسام مضادة غير مقترنة بداء معين.</li></ul><p dir="RTL"><strong>الأثار الجانبية الشائعة : يمكن أن تؤثر في مريض واحد من كل 10 مرضى:ـ</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; فرط الحساسية (رد فعل تحسسي) طفح وحمى بسبب هذه الدواء.</li><li>&nbsp; &nbsp; دوار وصداع وإحساس بوخز في فروة الرأس ، ويكون هذا بشكل&nbsp; مؤقت عادة ويحدث أثناء الأسابيع القليلة الأولى من العلاج.</li><li>&nbsp; &nbsp; رؤية ضبابية.</li><li>&nbsp; &nbsp; فشل القلب الاحتقاني.</li><li>&nbsp; &nbsp; &nbsp;دوار عند الانتقال بسرعة من وضع الرقود إلى الجلوس أو من وضع الجلوس إلى الوقوف ، وذلك بسبب انخفاض ضغط الدم ( هبوط ضغط الدم الوضعي) يحدث هذا بمعدل اكثر شيوعاً عند تعاطي جرعات عالية جداً أو إذا كانت الجرعة المبدئية عالية جداً أو إذا زيدت الجرعات بسرعة أكثر من اللازم يحدث هذا بشكل مؤقت عادة خلال الاسابيع القليلة الأولى من العلاج.</li><li>&nbsp; &nbsp; &nbsp; احتقان الأنف ويكون مؤقتاً عادة ويحدث أثناء الاسابيع القليلة الأولى من العلاج.</li><li>&nbsp; &nbsp; غثيان.</li><li>&nbsp; &nbsp; ارتفاع معدلات وظائف الكبد في اختبارات الدم عادة تعود هذه المعدلات إلى طبيعتها بعد سحب الدواء.</li><li>&nbsp; &nbsp; صعوبة في التبول.</li><li>&nbsp; &nbsp; عجز الانتصاب (ضعف جنسي) وفشل القذف.</li><li>&nbsp; &nbsp; تعب ونقص الطاقة ويكون هذا مؤقتاً عادة ويحدث أثناء الأسابيع القليلة الأولى من العلاج.</li></ul><p dir="RTL">تفاعلات تحسسية (فرط الحساسية) ويمكن أن تشمل طفح جلدي (بدرجات مختلفة) حكة ، ضيق التنفس ، ونادراً جداً حمى أو تورم سريع في الجلد.</p><p dir="RTL"><strong>آثار جانبية غير شائعة يمكن أن تؤثر في مريض واحد من كل 100 مريض:ـ</strong></p><ul dir="rtl"><li>&nbsp; &nbsp;مزاج مكتئب ، يحدث هذا بشكل مؤقت عادة خلال الاسابيع القليلة الأولى من العلاج.</li><li>&nbsp; &nbsp; &nbsp;انقباض عضلات القصبات الهوائية (تشنج قصبي).</li><li>&nbsp; &nbsp; قيء وألم في المعدة أسفل الضلوع مباشر.</li><li>&nbsp; &nbsp; &nbsp;عرق ، يحدث هذا بشكل مؤقت عادة خلال الأسابيع القليلة الأولى من العلاج.</li><li>&nbsp; &nbsp; تشنجات عضلية.</li></ul><p dir="RTL"><strong>أثار جانبية نادرة : يمكن أن تؤثر في شخص واحد من كل 1000 شخص:</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; انخفاض سرعة القلب ، يشعر به المريض في بطء النبض (بطء القلب).</li></ul><p dir="RTL"><strong>آثار جانبية نادرة جدا: يمكن أن تؤثر في مريض واحد من كل 10000 مريض:</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; رعشة عند استخدام ترانديت لعلاج ضغط الدم المرتفع المقترن بالحمل.</li><li>&nbsp; &nbsp; تهيج العين.</li><li>&nbsp; &nbsp; &nbsp; انقطاع النبضات الكهربائية التي تتحكم في نبض القلب (إحصار القلب).</li><li>&nbsp; &nbsp; تدهور أعراض متلازمة داء رينو (برودة الأصابع بسبب تقلص الشرايين الصغيرة).</li><li>&nbsp; &nbsp; التهاب الكبد ، يشفي عادة بعد سحب الدواء.</li><li>&nbsp; &nbsp; &nbsp;يرقان خلوي كبدي ( اصفرار الجلد وبياض العينين) يرقان ركودي (تشمل اعراضه التعب والغثيان متبوعين بحكة وبول داكن ويرقان وقد يشمل طفح جلدي وحمى) ونخر كبدي (تلف أنسجة الكبد) عادة تزول هذه الاعراض بعد سحب الدواء.</li><li>&nbsp; &nbsp; التهاب وضعف العضلات بسبب الدواء (اعتلال عضلي سمي).</li><li>&nbsp; &nbsp; الذئبة الحمامية الجهازية التي تشمل أعراضها ألم المفاصل والحمى وطفح جلدي وتعب.</li><li>&nbsp; &nbsp;العجز التام عن التبول حتى امتلاء المثانة بالكامل (حالة طبية طارئة).</li><li>&nbsp; &nbsp; تورم الكاحلين يحدث هذا بشكل مؤقت عادة خلال الأسابيع القليلة الأولى من العلاج.</li></ul><p dir="RTL"><strong>الإبلاغ عن آثار جانبية:ـ</strong></p><p dir="RTL">إذا أصبت بأي من الآثار الجانبية ، فينبغي استشارة الطبيب أو الصيدلي أو الممرضة يشمل هذا آثار جانبية ممكنة ليست مسرودة في هذه النشرة يمكنك ايضاً الإبلاغ عن أي آثار جانبية بشكل مباشر عن طريق النظام الوطني للإبلاغ عن الآثار الجانبية إن إبلاغك عن الآثار الجانبية يساعد في توفير معلومات إضافية عن سلامة استخدام هذا العقار.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>5- كيفية تخزين ترانديت:ـ</strong></p><p dir="RTL">يجب حفظ هذا الدواء بعيداً عن متناول الأطفال ونظرهم لا يؤخذ هذا الدواء بعد تاريخ انتهاء الصلاحية المكتوب علي العلبة الكرتونية أو الزجاجة بعد الأحرف EXP .</p><p dir="RTL">لا يحفظ في درجة حرارة أعلى من 25 درجة مئوية.</p><p dir="RTL">لا&nbsp; تستخدم هذا الدواء إذا لاحظت أي علامات على تدهوره.</p><p dir="RTL">لا تتخلص من أي أدوية في مياه الصرف الصحي أو النفايات المنزلية.</p><p dir="RTL">أسال الصيدلي عن كيفية التخلص من الأدوية التي لا تحتاج إليها ستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات ترانديت:</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; المادة الفعالة هي هيدروكلوريد لا بيتالول يحتوي القرص الواحد على 100 مجم أو 200مجم من مادة هيدروكلوريد لابيتالول .</li><li>&nbsp; &nbsp; &nbsp; المكونات الأخرى هي : في لب القرص : لا كتوز لا مائي ، سيرات ماغنيسيوم ، سيلولوز دقيق البلورات الغلاف الرقيق للقرص : صبغة أوباسبراي برتقالية أم -1-3499 دي (صبغة تحتوي علي بنزوات الصوديوم (مادة حافظة أي 211) ، هايبروميلوز ، ثاني أكسيد التيتانيوم (أي 171) ، صبغة صفراء برتقالية (أي 110) وهايبروميلوز.</li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل أقراص ترانديت ومحتويات العبوة:</strong></p><p dir="RTL">أقراص ترانديت تركيز 100مجم عبارة عن أقراص مغلفة بطبقة رقيقة ولونها برتقالي ومستديرة ومنحنية ومحدبة من الجانبين قطرها 8مم ومنقوش على أحد جانبي القرص الأحرف GS SC5 ، تتكون العبوة من حاويات مصنوعة من مادة بولي بروبيلين وأغطية من مادة بولي أيثيلين منخفضة الكثافة وتحتوي الحاوية على 50 قرصاً أو75قرصا 100 قرص أو 250 قرصاً.</p><p dir="RTL">أقراص ترانديت تركيز 200مجم عبارة عن أقراص مغلفة بطبقة رقيقة ولونها برتقالي ومستديرة محدبه الجنابين قطرها 9.5مم ومنقوش على احد جانبي القرص الأحرف GS FG7 تتكون العبوة من حاويات مصنوعة من مادة بولي بروبيلين وأغطية من مادة&nbsp; بولي إيثلين منخفضة الكثافة وتحتوي الحاوية على 50 قرصاً أو75 قرصا 100 قرص أو 250 قرصاً.</p><p dir="RTL">قد لا يتم تسويق العبوات بكل الأحجام</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة صاحبة تفويض التسويق:</strong></p><p dir="RTL">أسبن فارما تريدينج المحدودة</p><p dir="RTL">3016 ليك درايف.</p><p dir="RTL">سيتي ويست بزنس كامبوس</p><p dir="RTL">دوبلن 24 أيرلندا.</p><p dir="RTL"><strong>الشركة المصنعة:</strong>ـ</p><p dir="RTL">أسبن باد أولد سلوي المحدودة.</p><p dir="RTL">المنطقة الصناعية 32-36</p><p dir="RTL">د-23843 باد أولدسلوي</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم الموافقة على هذه النشرة بتاريخ 03/2014م 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trandate 100 mg film-coated tablets 
Trandate 200 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains:
Substance with known effect: Anhydrous lactose 14.6 mg respectively 29.3 mg per tablet, sunset yellow (E110).

For the full list of substances, please see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet
100 mg: orange, round, cupped, 8 mm, marked GS SC5 on one side.
200 mg: orange, round, cupped, 9.5 mm, marked GS FC7 on one side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Mild, moderate or severe hypertension</li><li>Pregnancy-related hypertension</li><li>Angina pectoris with concomitant hypertension</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Dosage<br />Population<br />Adults:</strong></u></p><table border="1" cellspacing="1" cellpadding="1" style="width:829px"><tbody><tr><td style="width:185px"><strong>Indication</strong></td><td style="width:643px"><strong>Dosage</strong></td></tr><tr><td style="width:185px"><strong>Mild, moderate or severe hypertension</strong></td><td style="width:643px">Treatment should start with 100 mg twice a day. If necessary the dose can be increased by 100 mg twice a day and with a range of 2 to 14 days. Many patients&#39; blood pressure is checked with 200 mg twice a day, and up to 800 mg per day can be divided into twotimes a day. In severe refractory hypertension, daily doses up to 2400 mg have been given (divided into three or four doses). Patients hospitalized with severe hypertension may increase the dose daily. Additional antihypertensive effects can be expected if labetalol tablets are given in conjunction with other blood-pressure medicines, such as diuretics, methyl dopa etc. If treatment is stopped for any reason, the dose should be decreased gradually. For long-term control of hypertension after use of labetalol injection,<br />oral treatment with labetalol tablets should start with 100 mg twice<br />a day.</td></tr><tr><td style="width:185px"><strong>Pregnancy-related hypertension</strong></td><td style="width:643px"><p>The initial doses of 100 mg twice a day may be increased if<br />necessary at weekly intervals, with 100 mg twice a day. Severity of hypertension may require three times a day.</p><p>A total daily dose of 2400 mg should not be exceeded.</p></td></tr><tr><td style="width:185px"><strong>Angina Pectoris with concomitant hypertension</strong></td><td style="width:643px">The dose labetalol is required to control the hypertension.</td></tr></tbody></table><p><u><strong>Paediatric population:</strong></u><br />Safety and effect of labetalol for children aged 0 to 18 years of age have not been established. No clinical data available.</p><p><u><strong>Elderly:</strong></u><br />For initiation of antihypertensive treatment, the usual starting dose is 100 mg orally twice daily.</p><p>Adequate blood pressure control can be achieved with lower maintenance doses than required in younger patients.</p><p><u><strong>Hepatic Impaired Patients:</strong></u><br />For patients with impaired liver function may lower doses of the oral preparation be required (please, see section 4 Warnings and Precautions).</p><p><u><strong>Method of Administration</strong></u><br />Labetalol tablets should be taken with food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Non-selective beta blockers should not be used in patients with asthma or history of obstructive airway disease.
- Labetalol injection and tablets are contraindicated in second or third degree heart block (unless the pacemaker is in situ), cardiogenic shock and other conditions associatedwith severe and prolonged hypotension or severe bradycardia
- Uncompensated heart failure Unstable/uncontrolled heart failure
- Sick sinus syndrome (including sino-atrial block) unless the pacemaker is in situ Prinzmetal angina
- Sinus node dysfunction
- Labetalol injection and tablets are contraindicated for patients with known hypersensitivity to the active substance or to any substance listed in section6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Liver disease</strong><br />Caution should be observed in liver disease. There have hardly ever been reports of severe hepatic cellular damage in labetalol treatment. Liver damage is usually reversible and has occurred after both short and long term treatment. Hepatic necrosis, in some cases with fatal outcome, have been reported, however. Laboratory testing should be carried out at the first sign or symptoms of liver dysfunction. If the laboratory results show liver damage or if the patient has signs of jaundice, the treatment should be suspended and not resumed.<br />Special caution should be taken when labetalol is used in patients with impaired liver function because they metabolize labetalol slower than patients without impaired liver function. Lower doses may be required (please, see section 4.2 Dosage and method of administration and 5.2 Pharmacodynamic properties - Special Patient Populations).</p><p><strong>Renal impairment</strong><br />Caution should be observed when labetalol is used for patients with severely impaired renal function (GFR = 15-29 ml/min/1.73 m<sup>2</sup>).</p><p><strong>Peripheral vascular disease</strong><br />Labetalol should be used with caution in patients with peripheral vascular disease because their symptoms may worsen. Caution should be observed in patients with peripheral artery disease (Raynaud&#39;s syndrome, intermittent claudication) as labetalol can aggravate their symptoms. Alpha blockers can counteract the undesirable effect of beta blockers.</p><p><strong>Symptomatic bradycardia</strong><br />If the patient develops symptomatic bradycardia, the dose should be reduced.</p><p><strong>First degree atrioventricular block</strong><br />In view of the negative impact of beta-adrenoceptor blocking drugs on the atrioventricular conduction time, labetalol should be given with caution to patients with first-degree atrioventricular block.</p><p><strong>Diabetes mellitus</strong><br />Caution should be taken in the uncontrolled or hard to control diabetes mellitus. As well as any beta- adrenoceptor blocking drugs, labetalol can hide the symptoms of hypoglycaemia (tachycardia and tremor) in diabetic patients. The hypoglycaemic effect of insulin and oral hypoglycaemic agents may be enhanced by beta blockers.</p><p><strong>Thyrotoxicosis</strong><br />Beta blockers may mask the symptoms of thyrotoxicosis but the thyroid function does not change.</p><p><strong>Hypersensitivity to beta blockers</strong><br />Risk of anaphylactic reaction: When patients with a history of severe anaphylactic reaction to various allergens use beta blockers, they can be more reactive to repeated provocation, whether it happens unintentionally, with diagnostic or therapeutic purposes. These patients may not respond to the usual doses of epinephrine used to treat an allergic reaction.</p><p><strong>Adrenaline</strong><br />If patients receiving labetalol need adrenaline treatment, a reduced adrenaline dose is used as co- administration with labetalol and adrenaline may cause bradycardia and hypertension (please, see section 4.5. Interactions with other drugs and other forms of interactions).</p><p>In case of significantly higher levels of adrenaline in the blood, such as pheochromocytoma, labetalol may cause a paradoxical increase of blood pressure.</p><p><strong>Rash and/ or dry eyes</strong><br />Skin rash and/or dry eye, associated with the use of beta-adrenoceptor blocking drugs, have been reported. The reported incidence is small and in most cases, the symptoms subsided when treatment was discontinued. Gradual discontinuation of the drug should be considered if such a response cannot be explained otherwise.</p><p><strong>Intraoperative Floppy Iris Syndrome</strong><br />The emergence of intraoperative floppy iris syndrome (IFIS, a variant of small pupil syndrome) has been observed in connection with cataract surgery in some patients treated with, or previously treated with tamsulosin. Occasional reports have also been received concerning other alpha-1 blockers and risk of drug class effect cannot be ruled out. Because the IFIS may lead to increased incidence of complications during cataract surgery, the eye surgeon should be pre-operatively informed of current or past use of alpha-1 blockers.</p><p><strong>Heart failure or ventricular function dysfunction</strong><br />Special caution should be observed in patients with heart failure or systolic left ventricular dysfunction. Labetalol is contraindicated in uncontrolled heart failure but can be used with caution in patients who are well controlled and symptom free. Heart failure should be controlled with adequate treatment before labetalol is used.</p><p>The use of beta blockers points to the risk of emergence of or worsening of heart failure or obstructive lung disease. In heart failure, the myocardial contraction ability should be maintained and the downturn compensated. Patients with reduced contraction ability, especially the elderly, should be monitored on a regular basis with regard to the emerging heart failure.</p><p>It is recommended that treatment with Trandate is not abruptly interrupted, especially in patients with congestive heart failure and in patients with angina pectoris (risk of aggravation of angina, myocardial infarction and ventricular fibrillation).</p><p><strong>Inhaled anaesthetics</strong><br />Caution should be taken in the event of simultaneous treatment with inhaled anaesthetics (please, see section 4.5. Interactions with other drugs and other interactions). Treatment with labetalol need not be interrupted before anaesthesia but the patient should intravenously be given atropine before the anaesthesia treatment begins. Labetalol may enhance the hypotensive effects of volatile anaesthetics.</p><p><strong>Metabolic acidosis and pheochromocytoma</strong><br />Caution should be taken in the event of metabolic acidosis and pheochromocytoma. In patients with pheochromocytoma, labetolol should only be given after adequate haemostasis is achieved.</p><p><strong>Calcium channel blockers</strong><br />Caution should be observed if labetalol is used at the same time as calcium channel blockers, particularly calcium flow inhibitors, which negatively affect the contraction ability and the AV conduction.</p><p>Caution should be taken in the event of simultaneous administration of adrenaline, verapamil or class I antiarrhythmic drugs (please, see section 4.5. Interactions with other drugs and other interactions).</p><p>Beta blockers have negative inotropic effect but do not affect the positive inotropic action of digitalis.</p><p><strong>Ischaemic heart disease</strong><br />Patients, and especially those with ischaemic heart disease, should not abruptly suspend or cancel the labetalol treatment. For patients with ischaemic heart disease, the treatment should, if possible, be gradually finished during 7 to 10 days.</p><p><strong>Help topic alerts: lactose and sunset yellow</strong><br />Patients with rare hereditary problems of galactose intolerance, total lactose deficiency or glucose, galactose malabsorption should not take this medicine.</p><p>The medicine contains sunset yellow colouring substance, which may cause hypersensitivity reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The hypotensive effect of labetalol may be reduced when used in combination with prostaglandin synthetase inhibitors (NSAIDS). Dose adjustments may therefore need to be done. More interactions may occur with other antihypertensives.</p><p>Labetalol fluoresces in alkaline solutions with an excitation wavelength of 334 nanometres and a fluorescence wavelength of 412 nm and can therefore interact with analysis of some fluorescent substances, including Catecholamines.</p><p>The presence of labetalol metabolites in the urine may indicate false elevated levels or urine catecholamines, metanephrine, normetanephrine and vanillylmandelic acid (VMA) when measured by fluorimetric or photometric methods. When patients with suspected pheochromocytoma and treated with labetalol hydrochloride are screened, a specific method, such as high-performance liquid chromatography with solid phase extraction, should be used for the determination of catecholamine levels.</p><p>Labetalol has been shown to reduce the absorption of radio-isotopes of meta iodo benzyl guanidine (MIBG). Accuracy should therefore be taken when interpreting the results of MIBG scintigraphy.</p><p>Co-administration of labetalol and adrenaline may cause bradycardia and hypertension (please, see section 4.4 Warnings and precautions).</p><p>Caution to be observed in case labetalol is used at the same time as either class I antiarrhythmic drugs or calcium channel blockers of the type verapamil.</p><p>Elevated risk of myocardial depression in combination with class I antiarrhythmic drugs (such as disopyramid and quinidine) and amiodarone (class II antiarrhythmic drugs).</p><p>Risk of severe bradycardia and hypotension in combination with calcium channel blockers with negative inotrope effect (e.g., verapamil, diltiazem). Especially for patients with impaired ventricular function and/or disruption of the conduction. When passing from a calcium channel to a beta blocker or vice versa, a new intravenous therapy should not be inserted until at least 48 hours after the last treatment was discontinued.</p><p>Simultaneous treatment with calcium channel blockers that are dihydro pyridine derivatives (e.g. nifedipine) may increase the risk of hypotension and may lead to heart failure in patients with heart failure. Digitalis glycosides in combination with beta blockers may extend the atrioventricular conduction time. Labetalol may strengthen digoxinets effect in terms of reducing the ventricular rate.</p><p>Beta blockers, particularly non-selective beta blocker, may increase the risk of hypoglycaemia in diabetes patients and hide the symptoms of hypoglycaemia, such as tachycardia and tremor, and slow down the normalization of blood sugar after insulin induced hypoglycaemia. Dose adjustments of oral anti-diabetic drugs and insulin may need to be done.</p><p>Caution should be observed in conjunction with general anaesthesia with patients using beta blockers. Beta blockers reduce the risk for arrhythmias during anaesthesia but may result in reduction of reflectance tachycardia and increase the risk of hypotension during anaesthesia. A vehicle with as low a negative inotrop effect as possible should be used for anaesthesia. Heart function must be carefully monitored and bradycardia due to vagal dominance be corrected with intravenous administration of atropine, 1-2 mg intravenously (release prior to surgery, please,see section 4.2 Posology and method of administration).</p><p>When it comes to the release of beta blockers and clonidine in patients using both vehicles, a gradual release of beta blocker must be made several days before clonidine is discontinued. The reason is to reduce the potentially recurrent hypertensive crisis resulting from that clonidine is discontinued.<br />When changing from clonidine to a beta blocker, therefore, it is important to gradually discontinue clonidine and begin treatment with a beta blocker several days after that, clonidine has been discontinued.</p><p>Simultaneous treatment with cholinesterase inhibitors may increase the risk of bradycardia.</p><p>Simultaneous treatment with alpha adrenergic stimulants may increase the risk of elevated blood pressure (e.g. phenylpropanolamine and adrenaline), whereas simultaneous treatment with beta- adrenergic stimulation results in a mutual reduced effect (antidote effect).</p><p>Simultaneous use of ergotamine may increase the risk of vaso spastisc reactions in some patients.</p><p>Labetalol has been shown to increase the bioavailability of imipramine with more than 50% depending on the inhibition of its 2-hydroxylation. Labetalol in combination with imipramine may increase the effect of imipramine. Simultaneous use of tricyclic antidepressants may increase the incidence of tremor.</p><p>Cimetidine may enhance the bioavailability of labetalol and caution is needed at oral doses of the latter substance. Improved blood pressure drop may be present at the simultaneous use of e.g. nitrates, antipsychotics (phenothiazines, such as chloropromazine) and other antipsychotics and antidepressants.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Fertility</u><br />There is no information on labetalols effect on fertility.</p><p><u>Pregnancy</u><br />Based on the experience of pregnancy in humans, labetalol does not increase the risk of birth defects. Animal studies do not indicate teratogenicity. Development of fetal toxic effects have, however, been noted (please, see section 5.3). Depending on the pharmacological mechanism of action of alpha-and beta-adrenoceptor blockers and when used in the latter part of pregnancy, side effects to the fetus and the newborn child are taken into account (bradycardia, hypotension, respiratory depression, hypoglycaemia), as labetalol passes over the placenta. Beta blockers can reduce blood flow in the uterus.</p><p>Labetalol should only be used during pregnancy if the benefits to the mother outweigh the risks to the fetus.</p><p><u>Breastfeeding:</u><br />Labetalol is secreted in the breast milk in small amounts (about 0,004&ndash; 0,7% of the maternal dose). No side effects have so far been reported. Caution should be observed when labetalol is given to breastfeeding women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The use of labetalol has probably no effect on the patient&#39;s ability to drive vehicles or operate machinery. It should be remembered that occasionally dizziness or fatigue may occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of the safety profile</strong><br />The most common side effects observed with labetalol tablets and gathered from the reports after the authorisation include: heart failure, postural hypotension, hypersensitivity, lichenoid rash, drug fever, increased liver function tests, urinary disorders, dizziness, headaches, tingling sensations in the scalp, blurred vision, nasal congestion, nausea, erectile dysfunction and ejaculation failure.</p><p><strong>Tabulated list of side effects</strong></p><p>The following convention has been used to classify the frequency:<br />Very common &ge;1/10<br />Common &ge;1/100, &lt;1/10<br />Less common &ge;1/1 000, &lt;1/100 Rare &ge;1/10 000, &lt;1/1000<br />Very rare &lt;1/10000</p><p>Side effects that are marked with a # are usually transient and occur during the first few weeks of treatment.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p>Organ system</p></td><td style="vertical-align:top"><p>Adverse effects</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Immune system</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Positive antinuclear antibodies not associated with disease</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hypersensitivity, lichenoid rash, drug fever</p></td></tr><tr><td style="vertical-align:top"><p>Mental disorders</p></td><td style="vertical-align:top"><p>Less common</p></td><td style="vertical-align:top"><p>#Depression</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Central and peripheral nervous system</p></td><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>#Dizziness, #headache, #tingling sensation of the scalp</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Tremor in the treatment of pregnancy-related hypertension</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Eyes</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Blurred vision</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Eye irritation</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Heart</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Heart failure</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Bradycardia</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Heart block</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Blood vessel</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>#Postural hypotension</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Worsening symptoms of Raynaud&#39;s syndrome</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>#Nasal congestion</p></td></tr><tr><td style="vertical-align:top"><p>Less common</p></td><td style="vertical-align:top"><p>Bronchospasm</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Nausea</p></td></tr><tr><td style="vertical-align:top"><p>Less common</p></td><td style="vertical-align:top"><p>Vomiting, epigastric pain</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Elevated liver function tests</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hepatitis, hepatocellular jaundice, cholestatic jaundice, hepatic necrosis</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue</p></td><td style="vertical-align:top"><p>Less common</p></td><td style="vertical-align:top"><p>#Sweating</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Musculoskeletal system and connective tissue</p></td><td style="vertical-align:top"><p>Less common</p></td><td style="vertical-align:top"><p>Convulsions</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Toxic myopathy, systemic lupus erythematosus</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Urinary disorders</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Acute urinary retention</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Erectile dysfunction, ejaculation failure</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>General symptoms and/or</p><p>symptoms at the site of administration</p></td><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>#Fatigue, #lethargy</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>#Foot oedema</p><p>&nbsp;</p></td></tr></tbody></table><p><strong>Description of some side effects:</strong></p><p><strong>Immune system</strong><br />Hypersensitivity reactions reported include rash (including reversible lichenoid rash), pruritus, dyspnoea, and, very rare drug fever and angio-oedema.</p><p><strong>Blood vessel</strong><br />Postural hypotension is more common in very high doses or if the starting dose is too high or the doses are too quickly increased.</p><p><strong>Liver and biliary tract</strong><br />Signs and symptoms of disorders of the liver and bile ducts are usually reversible upon release of the drug.</p><p><strong>To report any side effect(s):</strong><br />- In Saudi Arabia:</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>- The National Pharmacovigilance and Drug Safety Centre (NPC):<br />- Fax: 00966112057662<br />- Call NPC at 00966112038222, Exts: 2317-2356-2353-2354-2334-2340.<br />- Toll free phone: 8002490000<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: www.sfda.gov.sa/npc</td></tr></tbody></table><p>- Other GCC States:</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td>- Please contact the relevant competent authority.</td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms and signs</u><br />Significant cardiovascular effects can be expected, for example, comprehensive, postural hypotension and bradycardia at some point. Kidney failure with oliguria has been reported after massive oral overdose of labetalol. In one case, the use of dopamine in order to raise the blood pressure, has aggravated the kidney failure.</p><p><u>Treatment:</u><br />Patients should be placed supine with legs high up.</p><p>Parenteral adrenergic/anticholinergic therapy should be given as needed to improve circulation.</p><p>Haemodialysis removes less than 1% labetalol hydrochloride from the bloodstream.</p><p>Continued operation should be carried out as clinically indicated or in accordance with the recommendation of the poison control centre, if available.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Alpha-and beta-receptor blocking resources, ATC-code: C07AG01</p><p><strong>MOA</strong><br />Labetalol reduces blood pressure by blocking peripheral arteriolar alpha-adrenoceptors, thus reducing the peripheral resistance, and with simultaneous beta blockers, it protects the heart from reflex sympathetic work that would otherwise arise.</p><p><strong>Pharmacodynamic effects</strong><br />The cardiac volume is not significantly reduced at rest or after moderate exertion. Increase of systolic blood pressure in exertion will be smaller but the corresponding changes of diastolic pressure is basically normal. All of these effects can be expected to be beneficial for hypertensive patients.</p><p>In patients with angina pectoris and with hypertension, the reduced peripheral resistance reduces the heart load and oxygen demand. All these effects can be expected to be to the benefit of the hypertensive patients and those with simultaneous angina.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Pharmacodynamics</strong></u></p><p><strong>Absorption</strong><br />Labetalol chemically consists of four stereoisomers with different pharmacodynamic effects. Labetalol is rapidly absorbed from the gastrointestinal tract and the highest plasma levels occur 1 to 2 hours after oral administration. There is a significant first passageway metabolism that produces a bioavailability of about 25% but with considerable variations. The bioavailability of labetalol increases in older people.</p><p><strong>Distribution</strong><br />About 50% is protein-bound labetalol. Only negligible amounts of labetalol have crossed the blood- brain barrier in animal studies. Labetalol passes the placenta barrier and is excreted in breast milk.</p><p><strong>Metabolism</strong><br />Labetalol is metabolised mainly by conjugation to inactive glucuronide metabolites.</p><p><strong>Elimination:</strong><br />Glucuronide metabolites secreted both in urine and via the bile to the faeces. Less than 5% of the labetalol dose secreted unchanged in urine and bile. Half-life of labetalol in plasma is about 4 hours.</p><p><u><strong>Special patient populations</strong></u></p><p><strong>Liver failure</strong><br />Labetalol undergoes significant but varying first passageway metabolism when orally taken. In a study of 10 patients with histologically proven cirrhosis, exposure was increased to oral labetalol about three times compared to the healthy control group. Individual variations in both patients and control group were large (approximately 2.5 times). Patients with liver failure might need to be given lower oral doses of labetalol (please, see section 4.2 Posology and method of administration and section 4.4. Warnings and precautions).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Carcinogenic, mutagenic, and teratogenic effects</strong></u><br />There was no evidence of mutagenic potential in studies in vitro and in vivo.<br />Labetalol showed no evidence of carcinogenicity in long-term studies in mice and rats.<br />No teratogenicity was observed in rats and rabbits at oral doses of 6 and 4 times the maximum recommended dose for humans. Increased fetal resorptions could be seen in both species at doses approaching the maximum dose recommended for human use. A teratology study, performed with labetalol, on rabbit with intravenous doses up to 1.7 times the maximum recommended dose for human use, gave no evidence of drug-related harm to the fetus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet core:<br />Anhydrous lactose&nbsp;<br />Magnesium stearate<br />Microcrystalline cellulose</p><p>Tablet coating:<br />Opaspray orange M-1-3499D (dye, contains: sodium benzoate (E211), hypromellose, titanium dioxide (E171), sunset yellow (E110)) Hypromellose</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Must be kept at a temperature not exceeding 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>100 mg: plastic jar 100 pcs<br />200 mg: plastic jar 100 pcs</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aspen Pharma Trading Limited
3016 Lake Drive, Citywest Business Campus Dublin 24, Ireland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 /2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>